These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 33962149)

  • 1. Metabolic syndrome and its related biochemical derangements in breast cancer patients who received neoadjuvant chemotherapy: A study from a tertiary care oncology centre from Puducherry, South India.
    Gomes SL; Bobby Z; Ganesan P; Saroja K; Parameswari G R
    Diabetes Metab Syndr; 2021; 15(3):975-980. PubMed ID: 33962149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An observational study to examine changes in metabolic syndrome components in patients with breast cancer receiving neoadjuvant or adjuvant chemotherapy.
    Dieli-Conwright CM; Wong L; Waliany S; Bernstein L; Salehian B; Mortimer JE
    Cancer; 2016 Sep; 122(17):2646-53. PubMed ID: 27219902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment?
    Alan O; Akin Telli T; Aktas B; Koca S; Ökten IN; Hasanov R; Basoglu T; Arikan R; Demircan NC; Ercelep O; Kaya S; Ugurlu MU; Kaya H; Akgul Babacan N; Dane F; Yumuk PF
    World J Surg Oncol; 2020 Sep; 18(1):242. PubMed ID: 32907593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical derangements related to metabolic syndrome in epileptic patients on treatment with valproic acid.
    Nisha Y; Bobby Z; Wadwekar V
    Seizure; 2018 Aug; 60():57-60. PubMed ID: 29906708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship Between Metabolic Syndrome and Postmenopausal Breast Cancer.
    Ekinci O; Eren T; Kurtoglu Yakici M; Gapbarov A; Aydemir MA; Saglam ZA; Alimoglu O
    Cir Esp (Engl Ed); 2020 Nov; 98(9):540-546. PubMed ID: 32197778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Key metabolic parameters change significantly in early breast cancer survivors: an explorative PILOT study.
    Fredslund SO; Gravholt CH; Laursen BE; Jensen AB
    J Transl Med; 2019 Apr; 17(1):105. PubMed ID: 30935397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between metabolic syndrome components, low-grade systemic inflammation and insulin resistance in non-diabetic Indonesian adolescent male.
    Mansyur MA; Bakri S; Patellongi IJ; Rahman IA
    Clin Nutr ESPEN; 2020 Feb; 35():69-74. PubMed ID: 31987123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The actual scenario of neoadjuvant chemotherapy of breast cancer in developing country: a report of 80 cases of breast cancer from a tertiary cancer center in India.
    Das U; Lakshmaiah KC; Govind Babu K; Suresh TM; Lokanatha D; Jacob L; Babu S
    J Cancer Res Clin Oncol; 2014 Oct; 140(10):1777-82. PubMed ID: 24894013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of simple clinical parameters to predict insulin resistance among newly diagnosed patients with type 2 diabetes in limited resource settings.
    Wasana KGP; Attanayake AP; Weerarathna TP; Jayatilaka KAPW
    PLoS One; 2021; 16(3):e0248469. PubMed ID: 33788827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship of insulin resistance and metabolic syndrome with known breast cancer prognostic factors in postmenopausal breast cancer patients.
    Can A; Alacacioglu A; Kucukzeybek Y; Erten C; Cokmert S; Demir L; Dirican A; Vedat Bayoglu I; Akyol M; Aslan F; Oktay Tarhan M
    J BUON; 2013; 18(4):845-50. PubMed ID: 24344007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial.
    Hurvitz SA; Martin M; Symmans WF; Jung KH; Huang CS; Thompson AM; Harbeck N; Valero V; Stroyakovskiy D; Wildiers H; Campone M; Boileau JF; Beckmann MW; Afenjar K; Fresco R; Helms HJ; Xu J; Lin YG; Sparano J; Slamon D
    Lancet Oncol; 2018 Jan; 19(1):115-126. PubMed ID: 29175149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Multicenter Study of the Impact of Body Mass Index (BMI) on the incidence of Pathologic Complete Response (pCR) Among Saudi Patients with locally advanced Breast cancer (LABC) post Neoadjuvant Chemotherapy (NAC).
    Al-Saleh K; Abd El-Aziz N; Ali A; Abo Zeed W; Salah T; Elsamany S; Rasmy A; El Farargy O; Husain S; Al-Rikabi A; Alsaeed E; Aldiab A; Abd El-Warith A
    Gulf J Oncolog; 2019 May; 1(30):33-42. PubMed ID: 31242980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of diabetes and fasting plasma glucose on treatment of breast cancer with neoadjuvant chemotherapy.
    Arici S; Geredeli C; Secmeler S; Cekin R; Sakin A; Cihan S
    Curr Probl Cancer; 2020 Feb; 44(1):100485. PubMed ID: 31200961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance and metabolic syndrome in nonobese Indian patients with non-alcoholic fatty liver disease.
    Bhat G; Baba CS; Pandey A; Kumari N; Choudhuri G
    Trop Gastroenterol; 2013; 34(1):18-24. PubMed ID: 23923370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic fasting in patients with metabolic syndrome and impaired insulin resistance.
    Stange R; Pflugbeil C; Michalsen A; Uehleke B
    Forsch Komplementmed; 2013; 20(6):421-6. PubMed ID: 24434756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of metabolic syndrome in a north Indian hospital-based population with obstructive sleep apnoea.
    Agrawal S; Sharma SK; Sreenivas V; Lakshmy R
    Indian J Med Res; 2011 Nov; 134(5):639-44. PubMed ID: 22199102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial.
    Loibl S; O'Shaughnessy J; Untch M; Sikov WM; Rugo HS; McKee MD; Huober J; Golshan M; von Minckwitz G; Maag D; Sullivan D; Wolmark N; McIntyre K; Ponce Lorenzo JJ; Metzger Filho O; Rastogi P; Symmans WF; Liu X; Geyer CE
    Lancet Oncol; 2018 Apr; 19(4):497-509. PubMed ID: 29501363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homeostasis model assessment to detect insulin resistance and identify patients at high risk of breast cancer development: National Cancer Institute of Naples experience.
    Capasso I; Esposito E; Pentimalli F; Montella M; Crispo A; Maurea N; D'Aiuto M; Fucito A; Grimaldi M; Cavalcanti E; Esposito G; Brillante G; Lodato S; Pedicini T; D'Aiuto G; Ciliberto G; Giordano A
    J Exp Clin Cancer Res; 2013 Mar; 32(1):14. PubMed ID: 23497533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum complement C3 correlates with insulin resistance in never treated psoriatic arthritis patients.
    Ursini F; Grembiale A; Naty S; Grembiale RD
    Clin Rheumatol; 2014 Dec; 33(12):1759-64. PubMed ID: 24005838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete Metabolic Response on Interim
    Chen S; Ibrahim NK; Yan Y; Wong ST; Wang H; Wong FC
    Oncologist; 2017 May; 22(5):526-534. PubMed ID: 28377466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.